HighTower Advisors
TELA icon

HighTower Advisors’s TELA Bio TELA Stock Holding History

HighTower Advisors’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.4K Hold
11,200
– – ﹤0.01% 3788
2026
Q1 		$6.94K Buy
11,200
+848
+8% +$736 ﹤0.01% 3790
2025
Q4 		$12.2K Hold
10,352
– – ﹤0.01% 3631
2025
Q3 		$15.4K Sell
10,352
-6,000
-37% -$10.6K ﹤0.01% 3685
2025
Q2 		$31.7K Buy
16,352
+6,000
+58% +$7.85K ﹤0.01% 3584
2025
Q1 		$12.6K Buy
+10,352
New +$25.4K ﹤0.01% 3547

Other funds holding TELA

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
USWIA
UP Strategic Wealth Investment Advisors Pittsburgh, Pennsylvania $168M AUM 30.07% 1-Year Est. Return
EFG
Embree Financial Group Chicago, Illinois $999M AUM 24.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
DWP
Destiny Wealth Partners Tavares, Florida $709M AUM 19.96% 1-Year Est. Return
DWM
Ducere Wealth Management Newport Beach, California $333M AUM
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

HighTower Advisors's TELA Position: Q2 2026 in Review

HighTower Advisors held its TELA Bio (TELA) position steady in Q2 2026 at 11,200 shares worth $8.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3788.

HighTower Advisors first reported a position in TELA in Q1 2025 and has held it in 6 quarters since. The position peaked at $31.7K in Q2 2025. 15 funds tracked by Wall St. Rank hold TELA as of Q2 2026.

  • HighTower Advisors held 11,200 shares of TELA Bio worth $8.4K as of Q2 2026.
  • HighTower Advisors left its TELA Bio share count unchanged in Q2 2026.
  • TELA Bio made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #3788 holding.
  • HighTower Advisors first reported a position in TELA Bio in Q1 2025 and has held it in 6 quarters since.
  • HighTower Advisors's TELA Bio position peaked at $31.7K in Q2 2025.
  • 15 funds tracked by Wall St. Rank held TELA Bio as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.